Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Atrial Fibrillation
NCT05844501Phase 4Recruiting
- Sponsor
- Indiana University
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ondansetron in Atrial fibrillation (AFib), sponsored by Indiana University. Started Apr 2025; status: recruiting.
02
Drugs
ondansetron
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05844501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844501.